AU4174301A - Method for transdermal or intradermal delivery of molecules - Google Patents

Method for transdermal or intradermal delivery of molecules

Info

Publication number
AU4174301A
AU4174301A AU4174301A AU4174301A AU4174301A AU 4174301 A AU4174301 A AU 4174301A AU 4174301 A AU4174301 A AU 4174301A AU 4174301 A AU4174301 A AU 4174301A AU 4174301 A AU4174301 A AU 4174301A
Authority
AU
Australia
Prior art keywords
transdermal
molecules
intradermal delivery
intradermal
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4174301A
Other languages
English (en)
Inventor
Sen Arindam
Sek Wen Hui
Ya Li Zhao
Lei Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Research Inc
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of AU4174301A publication Critical patent/AU4174301A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
    • A61N1/0416—Anode and cathode
    • A61N1/0424—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A61N1/306—Arrangements where at least part of the apparatus is introduced into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
AU4174301A 2000-02-25 2001-02-26 Method for transdermal or intradermal delivery of molecules Pending AU4174301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18491800P 2000-02-25 2000-02-25
PCT/US2001/005997 WO2001062228A1 (en) 2000-02-25 2001-02-26 Method for transdermal or intradermal delivery of molecules

Publications (1)

Publication Number Publication Date
AU4174301A true AU4174301A (en) 2001-09-03

Family

ID=22678852

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4174301A Pending AU4174301A (en) 2000-02-25 2001-02-26 Method for transdermal or intradermal delivery of molecules
AU2001241743A Ceased AU2001241743B2 (en) 2000-02-25 2001-02-26 Method for transdermal or intradermal delivery of molecules

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001241743A Ceased AU2001241743B2 (en) 2000-02-25 2001-02-26 Method for transdermal or intradermal delivery of molecules

Country Status (7)

Country Link
US (1) US20020040203A1 (enExample)
EP (1) EP1280516A4 (enExample)
JP (1) JP2003523377A (enExample)
CN (1) CN1406125A (enExample)
AU (2) AU4174301A (enExample)
CA (1) CA2394088A1 (enExample)
WO (1) WO2001062228A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
WO2011115684A2 (en) 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
HK1197039A1 (zh) 2011-06-15 2015-01-02 Chrontech Pharma Ab 注射针和装置
CN102726194B (zh) * 2012-07-10 2013-07-03 浙江省萧山棉麻研究所 一种提高亮叶光萼荷繁殖系数的方法
JP2016533326A (ja) * 2013-09-27 2016-10-27 イーピー・テクノロジーズ・エルエルシーＥｐ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ スキンの複層組織に渡る分子デリバリのための方法及び装置
US20160089545A1 (en) * 2013-09-27 2016-03-31 EP Technologies LLC Methods and apparatus for delivery of molecules across layers of tissue
US10233419B2 (en) 2016-06-30 2019-03-19 Zymergen Inc. Apparatuses and methods for electroporation
CN111803789A (zh) * 2020-06-28 2020-10-23 王瑾 一种无创伤美唇方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US6190691B1 (en) * 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
CA2222328C (en) * 1995-06-07 2012-01-10 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5833647A (en) * 1995-10-10 1998-11-10 The Penn State Research Foundation Hydrogels or lipogels with enhanced mass transfer for transdermal drug delivery
WO2000002620A1 (en) * 1998-07-13 2000-01-20 Genetronics, Inc. Method and apparatus for electrically assisted topical delivery of agents for cosmetic applications

Also Published As

Publication number Publication date
JP2003523377A (ja) 2003-08-05
AU2001241743B2 (en) 2005-03-03
EP1280516A4 (en) 2003-06-11
CN1406125A (zh) 2003-03-26
CA2394088A1 (en) 2001-08-30
WO2001062228A1 (en) 2001-08-30
US20020040203A1 (en) 2002-04-04
EP1280516A1 (en) 2003-02-05

Similar Documents

Publication Publication Date Title
GB0014969D0 (en) Novel method of treatment
GB2364725B (en) Method for treatment of underground reservoirs
EP1419217A4 (en) PROCESS FOR TREATING LIQUID HYDROCARBON
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
GB9915354D0 (en) Method for treatment of underground reservoirs
EP1680178A4 (en) SYSTEM AND METHOD FOR THE TRANSDERMAL DISTRIBUTION OF A VACCINE
HUP0302926A3 (en) Composition for the transdermal delivery of fentanyl
EP1446087A4 (en) METHOD FOR TREATING NON-NEUROPATHIC PAIN
IL175088A0 (en) Method for transdermal delivery of permeant substances
AU2002210462A1 (en) Transdermal therapeutic system for treating restless-legs-syndrome
AU2002210881A1 (en) Transdermal method
EP1465968A4 (en) METHODS OF TREATING DISTILLATE DEODORIZER
AU2001286983A1 (en) Method of treatment
EP1442156A4 (en) electrophoresis
AU4174301A (en) Method for transdermal or intradermal delivery of molecules
EP1183032A4 (en) METHOD FOR IMPROVING INSULIN EFFECT
PL362462A1 (en) Apparatus for lipolysis for aesthetic treatment
GB2360646B (en) Method of displaying full-charge-state
EP1670416A4 (en) METHOD OF TREATING HYPERGLYCEMIA INDUCED BY IGF1R INHIBITORS
EP1435970A4 (en) METHOD OF TREATING SKIN WITH DIPHOSPHONATE DERIVATIVES
GB0026838D0 (en) Treatment method
AU2001262177A1 (en) Method of treatment
IL138013A0 (en) Method of safe infusion
GB2361698B (en) Modification of DNA molecules
GB0002762D0 (en) Method of treatment